The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Targeted deep sequencing from circulating plasma DNA as a multipurpose biomarker in pts (pts) referred for phase I trials.
Jean-Sebastien Frenel
No relevant relationships to disclose
Suzanne Carreira
No relevant relationships to disclose
Jane Goodall
No relevant relationships to disclose
Desamparados Roda
No relevant relationships to disclose
Alan David Smith
No relevant relationships to disclose
Joaquin Mateo
No relevant relationships to disclose
Michael Ong
No relevant relationships to disclose
Delila Gasi-Tandefelt
No relevant relationships to disclose
Timothy Anthony Yap
No relevant relationships to disclose
Gerhardt Attard
No relevant relationships to disclose
Ines Figueiredo
No relevant relationships to disclose
Daniel Nava Rodrigues
No relevant relationships to disclose
Penelope Flohr
No relevant relationships to disclose
L Rhoda Molife
No relevant relationships to disclose
Stanley B. Kaye
No relevant relationships to disclose
Udai Banerji
No relevant relationships to disclose
Johann Sebastian De Bono
No relevant relationships to disclose